Rating History for Iovanace Biotherapeutics (IOVA) by Goldman Sachs

More Stocks Rated by Goldman Sachs | Latest Ratings for IOVA
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
9/24/2026 Andrea Newkirk New Coverage Buy
(N/A)		 15.00
(N/A)		 10.64
(14.09)		 32.42% Details